Yahoo

Asian Stocks Estimated To Be Trading At Discounts Ranging From 10% To 48.2%

As global markets navigate a mix of economic signals, from cooling consumer price inflation in the U.S. to Japan's political developments and China's regulatory adjustments, investors are closely watching for opportunities in undervalued stocks across Asia. In this context, identifying stocks trading at significant discounts can be appealing, especially when market conditions suggest potential for value-oriented investments amidst broader economic shifts.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Name

Current Price

Fair Value (Est)

Discount (Est)

Zhongji Innolight (SZSE:300308)

CN¥585.00

CN¥1155.27

49.4%

Xizang Tianlu (SHSE:600326)

CN¥11.80

CN¥23.38

49.5%

Smoore International Holdings (SEHK:6969)

HK$10.98

HK$21.79

49.6%

PharmaResearch (KOSDAQ:A214450)

â‚©424500.00

â‚©846427.45

49.8%

Ningxia Building Materials GroupLtd (SHSE:600449)

CN¥13.11

CN¥25.98

49.5%

Money Forward (TSE:3994)

¥4284.00

¥8392.49

49%

MNC SolutionLtd (KOSE:A484870)

â‚©159500.00

â‚©313647.01

49.1%

Komehyo HoldingsLtd (TSE:2780)

¥3465.00

¥6809.31

49.1%

GCH Technology (SHSE:688625)

CN¥58.84

CN¥115.04

48.9%

Andes Technology (TWSE:6533)

NT$244.50

NT$482.31

49.3%

Click here to see the full list of 258 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Angelalign Technology

Overview:Angelalign Technology Inc. is an investment holding company that specializes in the research, design, manufacture, sale, and marketing of clear aligner treatment solutions in China and internationally, with a market cap of HK$11.98 billion.

Operations:The company's revenue is primarily derived from its Dental Equipment & Supplies segment, totaling $308.87 million.

Estimated Discount To Fair Value:17.5%

Angelalign Technology is trading at HK$70.15, below its estimated fair value of HK$85.06, indicating it could be undervalued based on cash flows. Its revenue is expected to grow 16.1% annually, outpacing the Hong Kong market's 8.4%. Earnings are projected to rise significantly over the next three years, with a forecast growth rate of 21.1% annually compared to the market's 12.3%. Recent innovations in their iOrtho platform and strategic management changes further position Angelalign for growth.

SEHK:6699 Discounted Cash Flow as at Jan 2026
SEHK:6699 Discounted Cash Flow as at Jan 2026

Beijing HyperStrong Technology

Overview:Beijing HyperStrong Technology Co., Ltd. focuses on the design, development, integration, and operation of energy storage power stations in China with a market cap of CN¥46.44 billion.

Operations:Revenue Segments (in millions of CN¥):

Estimated Discount To Fair Value:48.2%

Beijing HyperStrong Technology, currently trading at CN¥257.87, is priced 48.2% below its estimated fair value of CN¥497.58, highlighting potential undervaluation based on cash flows. The company forecasts robust earnings growth of 49.07% annually, surpassing the Chinese market's average growth rate of 28.1%. Additionally, revenue is expected to increase by 46.5% annually over the next three years, despite recent share price volatility impacting investor sentiment since November's earnings call announcement.

SHSE:688411 Discounted Cash Flow as at Jan 2026
SHSE:688411 Discounted Cash Flow as at Jan 2026

Shenzhen Kedali Industry

Overview:Shenzhen Kedali Industry Co., Ltd. engages in the research, development, manufacturing, and sale of lithium battery precision and automotive structural parts both in China and internationally, with a market cap of CN¥45.42 billion.

Operations:The company's revenue primarily comes from metal structure manufacturing, totaling CN¥14.02 billion.

Estimated Discount To Fair Value:10%

Shenzhen Kedali Industry, trading at CN¥165.18, is valued 10% below its fair value of CN¥183.55, reflecting potential undervaluation based on cash flows. Despite a relatively unstable dividend history and earnings growth forecasted at 23% annually—below the Chinese market's average—revenue is expected to grow faster than the market at 21.4% per year. Recent earnings for nine months ending September 2025 showed increased sales and net income compared to the previous year, supporting positive financial momentum.

SZSE:002850 Discounted Cash Flow as at Jan 2026
SZSE:002850 Discounted Cash Flow as at Jan 2026

Taking Advantage

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:6699 SHSE:688411 and SZSE:002850.

This article was originally published by Simply Wall St .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: